Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Peak Biotech A/S
A/S
Active
CVR 28892152
Bøgeskovvej 18A, 3490
Kvistgård
Manufacture of other special-purpose machinery n.e.c.
·
NACE 2899
Est. 2005 · 21 years old
8 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of other special-purpose machinery n.e.c.
/
Peak Biotech A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
36M
27M
18M
9M
0M
2021: 9M
9M
2021
2022: 9M (0% vs 2021)
9M
0%
2022
2023: 8M (-11% vs 2022)
8M
-11%
2023
2024: 22M (+175% vs 2023)
22M
+175%
2024
2025: 29M (+32% vs 2024)
29M
+32%
2025
EBITDA
DKK millions
35M
26M
17M
9M
0M
2021: 7M
7M
2021
2022: 6M (-14% vs 2021)
6M
-14%
2022
2023: 5M (-17% vs 2022)
5M
-17%
2023
2024: 21M (+320% vs 2023)
21M
+320%
2024
2025: 28M (+33% vs 2024)
28M
+33%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
29.438
22.439
8.045
8.782
9.118
Staff expenses
-0
-0
-3.114
-2.369
-2.477
EBITDA
27.684
21.034
4.930
6.413
6.641
Depreciation & amort.
-0
-0
-4
-0
-0
EBIT
27.684
21.034
4.927
6.413
6.641
Net financials
346
131
-597
-351
-105
Profit before tax
28.030
21.165
4.330
6.061
6.536
Tax
6.169
4.658
955
1.346
1.439
Net profit
21.861
16.506
3.374
4.715
5.097
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
94.508
48.719
45.755
27.130
14.151
Equity
43.994
22.133
13.577
10.653
11.038
Long-term debt
0
0
0
0
0
Short-term debt
50.513
26.574
32.171
16.478
3.113
Total debt
50.513
26.574
32.171
16.478
3.113
Financial ratios
5-year trend
EBITDA margin (of gross profit)
94,0 %
This company
2021
2025
Equity ratio
46,6 %
This company
38,2 %
Market median
This company
Market median
22% above market
2021
2025
Return on equity
49,7 %
This company
18,4 %
Market median
This company
Market median
170% above market
2021
2025
Net profit margin (of gross profit)
74,3 %
This company
2021
2025
Asset turnover (of gross profit)
0,31×
This company
2021
2025
Debt / equity
1,15×
This company
0,62×
Market median
This company
Market median
85% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
View
PDF
More on Peak Biotech A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
